US45166A1025
US45166A1025
IDEAYA Biosciences, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 218.710.000 | 7.000.000 | 3024.4% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| 378.023.000 | 333.975.000 | 13.2% | |
| Operating Income | -159.313.000 | -326.975.000 | 51.3% |
| Pretax Income | -113.698.000 | -274.477.000 | 58.6% |
| Net Income Common Stockholders | -113.698.000 | -274.477.000 | 58.6% |
| -- | -- | -- | |
| -- | -- | -- |